Palleon Pharmaceuticals, a company pioneering glyco-immunology drug development to treat autoimmune diseases and cancer, today announced a collaboration and license agreement with Shanghai Henlius ...

Bristol Myers Squibb has turned to the source of Leqembi to further its push into Alzheimer’s disease, paying BioArctic $100 ...

An analysis of over 3,700 pregnancies of women with multiple sclerosis indicates that the therapy doesn’t lead to increased risks of miscarriage, premature birth or serious birth defects.

Inside the “conundrum” of Botox resistance. Theories behind why one woman is “just not freezing” like she used to and experts ...

After experiencing hair thinning for over a year, I was diagnosed with incomplete lupus by a rheumatologist. My blood markers were high, but I don't have typical symptoms. My primary care physician ...

Structural Genomics Consortium researchers at The Neuro (Montreal Neurological Institute-Hospital) of McGill University, in ...

Researchers developing Australia’s first mRNA Covid vaccine say they may have solved the one of the biggest problems with ...

Penn Engineers have modified lipid nanoparticles (LNPs) -; the revolutionary technology behind the COVID-19 mRNA vaccines -; to not only cross the blood-brain barrier (BBB) but also to target specific ...

By Charles Buchanan For people living with autoimmune diseases, their condition can cast a constant shadow over nearly every ...

Protein deficiency is rare in the United States, but some people are at risk for it. Learn the symptoms of protein deficiency ...

Viridian's veligrotug shows promising results in treating TED patients, setting the stage for future growth in the ...

Researchers have developed and standardized an Open Science platform to characterize research antibodies. This platform, ...